These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31436833)

  • 1. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
    Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
    Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
    Galloway-Peña JR; Smith DP; Sahasrabhojane P; Ajami NJ; Wadsworth WD; Daver NG; Chemaly RF; Marsh L; Ghantoji SS; Pemmaraju N; Garcia-Manero G; Rezvani K; Alousi AM; Wargo JA; Shpall EJ; Futreal PA; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
    Cancer; 2016 Jul; 122(14):2186-96. PubMed ID: 27142181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.
    Franklin S; Aitken SL; Shi Y; Sahasrabhojane PV; Robinson S; Peterson CB; Daver N; Ajami NA; Kontoyiannis DP; Shelburne SA; Galloway-Peña J
    Front Cell Infect Microbiol; 2022; 12():848580. PubMed ID: 35433514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
    Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
    Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients.
    McMahon S; Sahasrabhojane P; Kim J; Franklin S; Chang CC; Jenq RR; Hillhouse AE; Shelburne SA; Galloway-Peña J
    Microbiol Spectr; 2023 Jun; 11(3):e0041523. PubMed ID: 37022173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.
    Robinson S; Peterson CB; Sahasrabhojane P; Ajami NJ; Shelburne SA; Kontoyiannis DP; Galloway-Peña JR
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy.
    Aitken SL; Sahasrabhojane PV; Kontoyiannis DP; Savidge TC; Arias CA; Ajami NJ; Shelburne SA; Galloway-Peña JR
    Clin Infect Dis; 2021 May; 72(9):1507-1513. PubMed ID: 32544947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
    Rattanathammethee T; Tuitemwong P; Thiennimitr P; Sarichai P; Na Pombejra S; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
    PLoS One; 2020; 15(10):e0236460. PubMed ID: 33112882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia.
    Rashidi A; Kaiser T; Shields-Cutler R; Graiziger C; Holtan SG; Rehman TU; Wasko J; Weisdorf DJ; Dunny G; Khoruts A; Staley C
    Sci Rep; 2019 Apr; 9(1):6083. PubMed ID: 30988420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
    Nedved AN; DeFrates SR; Hladnik LM; Stockerl-Goldstein KE
    Pharmacotherapy; 2016 Oct; 36(10):1087-1094. PubMed ID: 27521990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasting shift in the gut microbiota in patients with acute myeloid leukemia.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Halaweish HF; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
    Blood Adv; 2022 Jun; 6(11):3451-3457. PubMed ID: 35192686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia.
    Hakim H; Dallas R; Wolf J; Tang L; Schultz-Cherry S; Darling V; Johnson C; Karlsson EA; Chang TC; Jeha S; Pui CH; Sun Y; Pounds S; Hayden RT; Tuomanen E; Rosch JW
    Clin Infect Dis; 2018 Aug; 67(4):541-548. PubMed ID: 29518185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.
    Chen Z; Radjabzadeh D; Chen L; Kurilshikov A; Kavousi M; Ahmadizar F; Ikram MA; Uitterlinden AG; Zhernakova A; Fu J; Kraaij R; Voortman T
    JAMA Netw Open; 2021 Jul; 4(7):e2118811. PubMed ID: 34323983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.
    Tober R; Schnetzke U; Fleischmann M; Yomade O; Schrenk K; Hammersen J; Glaser A; Thiede C; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1569-1583. PubMed ID: 35583829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
    Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
    Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia.
    Løhmann DJA; Asdahl PH; Abrahamsson J; Ha SY; Jónsson ÓG; Kaspers GJL; Koskenvuo M; Lausen B; De Moerloose B; Palle J; Zeller B; Hasle H
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27231. PubMed ID: 29781563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis.
    Shen Z; Gu X; Cao H; Mao W; Yang L; He M; Zhang R; Zhou Y; Liu K; Wang L; Liu L; Yu J; Yin L
    Int Microbiol; 2021 May; 24(2):263-273. PubMed ID: 33604753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of COVID-19 precautions on the gut microbiota and nosocomial infections.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
    Gut Microbes; 2021; 13(1):1-10. PubMed ID: 34132630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome.
    Papanicolas LE; Sims SK; Taylor SL; Miller SJ; Karapetis CS; Wesselingh SL; Gordon DL; Rogers GB
    BMC Cancer; 2021 May; 21(1):591. PubMed ID: 34022842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.